key: cord-0849595-v7ugypzv
authors: Ghodsizad, Ali; Gant, April; Koerner, Michael M.; Loebe, Matthias
title: Venovenous ECMO application as bridge to recovery or lung transplantation; ongoing challenge as we look at a pre‐ and post‐COVID‐19 era
date: 2021-08-05
journal: J Card Surg
DOI: 10.1111/jocs.15892
sha: 0bb59d4a250e1b096047f7dc881b8c305ec364d6
doc_id: 849595
cord_uid: v7ugypzv

nan

Our survival to transfer or discharge rate has clearly been below 50%.

The statement "it is actually like the flu!" was not well-grounded and it still is not.

Once COVID patients develop barotrauma and bronchopulmonary fistula it becomes an even bigger challenge managing ARDS without being able to use high PEEP ventilation. 3 have published their data with more or less favorable results. 6 Future studies will show more predictive data and results as we engage more COVID-19 pandemic-related challenges.

Outcomes of extracorporeal membrane oxygenation in influenza vs. COVID-19 during the first wave of COVID-19

Refractory traumatic bronchopleural fistula: is extracorporeal membrane oxygenation the new gold standard?

Intravenous mesenchymal stem cells in extracorporeal oxygenation patients with severe COVID-19 acute respiratory distress syndrome

Characteristics and outcomes of patients with COVID-19 supported by extracorporeal membrane oxygenation: a retrospective multicenter study

Venovenous ECMO application as bridge to recovery or lung transplantation; ongoing challenge as we look at a pre-and post-COVID-19 era

http://orcid.org/0000-0003-1804-2375Matthias Loebe http://orcid.org/0000-0001-5694-0913